December 15, 2016
Biocartis CE-marks Idylla NRAS-BRAF Mutation Test
Biocartis has CE-marked its solid biopsy Idylla NRAS-BRAF Mutation Test. On Thursday, Biocartis said that, together with the CE-marked Idylla…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: metastatic colorectal cancer
September 22, 2015
Taiho Oncology’s Lonsurf approved in USA
The U. S. Food and Drug Administration approved Taiho Oncology’s Lonsurf for the treatment of patients with metastatic colorectal cancer who…